DE102012109727A1 - Enterosorbenszusammensetzung - Google Patents

Enterosorbenszusammensetzung Download PDF

Info

Publication number: DE102012109727A1
Authority: DE; Germany
Prior art keywords: polymethylsiloxane; intestinal; acid; hydrogel; aqueous solution
Prior art date: 2011-11-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

DE102012109727A

Other languages

German (de)

English (en)

Inventor

Vadim Kozolovskyi

Yuriy Tolcheyev

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-11-23

Filing date

2012-10-12

Publication date

2013-05-23

2012-10-12 Application filed by Individual filed Critical Individual

2013-05-23 Publication of DE102012109727A1 publication Critical patent/DE102012109727A1/de

Status Pending legal-status Critical Current

Links

-1 polymethylsiloxane Polymers 0.000 claims abstract description 41
238000002360 preparation method Methods 0.000 claims abstract description 28
239000000203 mixture Substances 0.000 claims abstract description 24
239000000017 hydrogel Substances 0.000 claims abstract description 22
FXSGDOZPBLGOIN-UHFFFAOYSA-N trihydroxy(methoxy)silane Chemical compound CO[Si](O)(O)O FXSGDOZPBLGOIN-UHFFFAOYSA-N 0.000 claims abstract description 21
229920001282 polysaccharide Polymers 0.000 claims abstract description 18
239000005017 polysaccharide Substances 0.000 claims abstract description 18
150000004804 polysaccharides Chemical class 0.000 claims abstract description 17
JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 claims abstract description 12
229960000511 lactulose Drugs 0.000 claims abstract description 11
PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 claims abstract description 11
229920001202 Inulin Polymers 0.000 claims abstract description 9
JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 9
229940029339 inulin Drugs 0.000 claims abstract description 9
229920001661 Chitosan Polymers 0.000 claims abstract description 8
229920005610 lignin Polymers 0.000 claims abstract description 5
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims abstract description 4
235000010443 alginic acid Nutrition 0.000 claims abstract description 4
229920000615 alginic acid Polymers 0.000 claims abstract description 4
239000001814 pectin Substances 0.000 claims abstract description 4
229920001277 pectin Polymers 0.000 claims abstract description 4
235000010987 pectin Nutrition 0.000 claims abstract description 4
229920000642 polymer Polymers 0.000 claims abstract description 4
150000003839 salts Chemical class 0.000 claims abstract description 4
FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims abstract description 3
229920002498 Beta-glucan Polymers 0.000 claims abstract description 3
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims abstract description 3
239000000783 alginic acid Substances 0.000 claims abstract description 3
229960001126 alginic acid Drugs 0.000 claims abstract description 3
150000004781 alginic acids Chemical class 0.000 claims abstract description 3
229910052710 silicon Inorganic materials 0.000 claims abstract description 3
239000010703 silicon Substances 0.000 claims abstract description 3
239000007864 aqueous solution Substances 0.000 claims description 31
239000002775 capsule Substances 0.000 claims description 7
239000000843 powder Substances 0.000 claims description 5
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
229920000591 gum Polymers 0.000 claims description 2
244000005709 gut microbiome Species 0.000 abstract description 10
238000010606 normalization Methods 0.000 abstract description 7
229920001938 Vegetable gum Polymers 0.000 abstract description 5
208000027244 Dysbiosis Diseases 0.000 description 26
230000007140 dysbiosis Effects 0.000 description 26
238000011282 treatment Methods 0.000 description 23
230000000968 intestinal effect Effects 0.000 description 21
244000005706 microflora Species 0.000 description 20
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 19
210000001035 gastrointestinal tract Anatomy 0.000 description 14
244000005700 microbiome Species 0.000 description 14
201000010099 disease Diseases 0.000 description 13
230000035987 intoxication Effects 0.000 description 12
231100000566 intoxication Toxicity 0.000 description 12
238000000034 method Methods 0.000 description 12
235000013406 prebiotics Nutrition 0.000 description 12
208000011580 syndromic disease Diseases 0.000 description 12
239000003242 anti bacterial agent Substances 0.000 description 11
229940088710 antibiotic agent Drugs 0.000 description 11
238000011161 development Methods 0.000 description 11
239000006041 probiotic Substances 0.000 description 11
235000018291 probiotics Nutrition 0.000 description 11
230000018109 developmental process Effects 0.000 description 10
241000186000 Bifidobacterium Species 0.000 description 9
208000036649 Dysbacteriosis Diseases 0.000 description 9
239000003814 drug Substances 0.000 description 9
239000002594 sorbent Substances 0.000 description 9
229940079593 drug Drugs 0.000 description 8
230000000694 effects Effects 0.000 description 8
238000001179 sorption measurement Methods 0.000 description 8
241000894006 Bacteria Species 0.000 description 7
206010012735 Diarrhoea Diseases 0.000 description 7
230000001717 pathogenic effect Effects 0.000 description 7
229960002181 saccharomyces boulardii Drugs 0.000 description 7
206010022678 Intestinal infections Diseases 0.000 description 6
241000186660 Lactobacillus Species 0.000 description 6
208000035475 disorder Diseases 0.000 description 6
210000000936 intestine Anatomy 0.000 description 6
239000000047 product Substances 0.000 description 6
239000000126 substance Substances 0.000 description 6
239000003826 tablet Substances 0.000 description 6
IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 5
230000009471 action Effects 0.000 description 5
230000003115 biocidal effect Effects 0.000 description 5
210000004027 cell Anatomy 0.000 description 5
238000012937 correction Methods 0.000 description 5
230000006870 function Effects 0.000 description 5
235000011837 pasties Nutrition 0.000 description 5
239000000661 sodium alginate Substances 0.000 description 5
235000010413 sodium alginate Nutrition 0.000 description 5
229940005550 sodium alginate Drugs 0.000 description 5
239000000243 solution Substances 0.000 description 5
238000002560 therapeutic procedure Methods 0.000 description 5
241001465754 Metazoa Species 0.000 description 4
240000004808 Saccharomyces cerevisiae Species 0.000 description 4
230000001154 acute effect Effects 0.000 description 4
230000029087 digestion Effects 0.000 description 4
235000013870 dimethyl polysiloxane Nutrition 0.000 description 4
239000004205 dimethyl polysiloxane Substances 0.000 description 4
208000015181 infectious disease Diseases 0.000 description 4
238000004519 manufacturing process Methods 0.000 description 4
244000000010 microbial pathogen Species 0.000 description 4
210000004400 mucous membrane Anatomy 0.000 description 4
229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
230000008569 process Effects 0.000 description 4
230000009467 reduction Effects 0.000 description 4
208000035473 Communicable disease Diseases 0.000 description 3
241000607142 Salmonella Species 0.000 description 3
244000309464 bull Species 0.000 description 3
230000001684 chronic effect Effects 0.000 description 3
230000006378 damage Effects 0.000 description 3
230000001079 digestive effect Effects 0.000 description 3
206010016766 flatulence Diseases 0.000 description 3
239000000499 gel Substances 0.000 description 3
230000000813 microbial effect Effects 0.000 description 3
230000001936 parietal effect Effects 0.000 description 3
231100000614 poison Toxicity 0.000 description 3
239000000725 suspension Substances 0.000 description 3
239000003440 toxic substance Substances 0.000 description 3
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
241000222120 Candida <Saccharomycetales> Species 0.000 description 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
241000193163 Clostridioides difficile Species 0.000 description 2
241000305071 Enterobacterales Species 0.000 description 2
241000233866 Fungi Species 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
241000588748 Klebsiella Species 0.000 description 2
241000588769 Proteus <enterobacteria> Species 0.000 description 2
241000700159 Rattus Species 0.000 description 2
241000191967 Staphylococcus aureus Species 0.000 description 2
229910052784 alkaline earth metal Inorganic materials 0.000 description 2
230000003042 antagnostic effect Effects 0.000 description 2
238000013459 approach Methods 0.000 description 2
230000001580 bacterial effect Effects 0.000 description 2
230000008859 change Effects 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
230000000112 colonic effect Effects 0.000 description 2
235000013325 dietary fiber Nutrition 0.000 description 2
238000001035 drying Methods 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
210000004051 gastric juice Anatomy 0.000 description 2
230000036541 health Effects 0.000 description 2
238000011835 investigation Methods 0.000 description 2
210000002429 large intestine Anatomy 0.000 description 2
150000002632 lipids Chemical class 0.000 description 2
239000002207 metabolite Substances 0.000 description 2
210000000110 microvilli Anatomy 0.000 description 2
230000035755 proliferation Effects 0.000 description 2
238000011321 prophylaxis Methods 0.000 description 2
210000000813 small intestine Anatomy 0.000 description 2
239000000829 suppository Substances 0.000 description 2
208000024891 symptom Diseases 0.000 description 2
238000002636 symptomatic treatment Methods 0.000 description 2
230000001225 therapeutic effect Effects 0.000 description 2
230000008359 toxicosis Effects 0.000 description 2
239000003053 toxin Substances 0.000 description 2
231100000765 toxin Toxicity 0.000 description 2
108700012359 toxins Proteins 0.000 description 2
BUHVIAUBTBOHAG-FOYDDCNASA-N (2r,3r,4s,5r)-2-[6-[[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]amino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound COC1=CC(OC)=CC(C(CNC=2C=3N=CN(C=3N=CN=2)[C@H]2[C@@H]([C@H](O)[C@@H](CO)O2)O)C=2C(=CC=CC=2)C)=C1 BUHVIAUBTBOHAG-FOYDDCNASA-N 0.000 description 1
HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
208000030507 AIDS Diseases 0.000 description 1
208000004998 Abdominal Pain Diseases 0.000 description 1
208000029483 Acquired immunodeficiency Diseases 0.000 description 1
XKJMBINCVNINCA-UHFFFAOYSA-N Alfalone Chemical compound CON(C)C(=O)NC1=CC=C(Cl)C(Cl)=C1 XKJMBINCVNINCA-UHFFFAOYSA-N 0.000 description 1
206010006895 Cachexia Diseases 0.000 description 1
241000222122 Candida albicans Species 0.000 description 1
229920002101 Chitin Polymers 0.000 description 1
241001112696 Clostridia Species 0.000 description 1
241000193403 Clostridium Species 0.000 description 1
206010009657 Clostridium difficile colitis Diseases 0.000 description 1
206010009900 Colitis ulcerative Diseases 0.000 description 1
208000005156 Dehydration Diseases 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
241000194033 Enterococcus Species 0.000 description 1
241000709661 Enterovirus Species 0.000 description 1
241000588722 Escherichia Species 0.000 description 1
206010048714 Gastroduodenitis Diseases 0.000 description 1
208000018522 Gastrointestinal disease Diseases 0.000 description 1
229920002907 Guar gum Polymers 0.000 description 1
102000000543 Histamine Receptors Human genes 0.000 description 1
108010002059 Histamine Receptors Proteins 0.000 description 1
208000031226 Hyperlipidaemia Diseases 0.000 description 1
206010021135 Hypovitaminosis Diseases 0.000 description 1
206010021143 Hypoxia Diseases 0.000 description 1
206010061598 Immunodeficiency Diseases 0.000 description 1
208000029462 Immunodeficiency disease Diseases 0.000 description 1
206010021746 Infantile colic Diseases 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
206010025476 Malabsorption Diseases 0.000 description 1
208000004155 Malabsorption Syndromes Diseases 0.000 description 1
208000001145 Metabolic Syndrome Diseases 0.000 description 1
208000012868 Overgrowth Diseases 0.000 description 1
208000002193 Pain Diseases 0.000 description 1
206010033645 Pancreatitis Diseases 0.000 description 1
208000037273 Pathologic Processes Diseases 0.000 description 1
241000235645 Pichia kudriavzevii Species 0.000 description 1
208000005374 Poisoning Diseases 0.000 description 1
208000003100 Pseudomembranous Enterocolitis Diseases 0.000 description 1
241000589517 Pseudomonas aeruginosa Species 0.000 description 1
241000702670 Rotavirus Species 0.000 description 1
241000831652 Salinivibrio sharmensis Species 0.000 description 1
206010039438 Salmonella Infections Diseases 0.000 description 1
241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 1
241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
206010054979 Secondary immunodeficiency Diseases 0.000 description 1
206010040047 Sepsis Diseases 0.000 description 1
241000607764 Shigella dysenteriae Species 0.000 description 1
241000607762 Shigella flexneri Species 0.000 description 1
241000295644 Staphylococcaceae Species 0.000 description 1
201000006704 Ulcerative Colitis Diseases 0.000 description 1
241000607626 Vibrio cholerae Species 0.000 description 1
241000700605 Viruses Species 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
208000019790 abdominal distention Diseases 0.000 description 1
201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
230000004913 activation Effects 0.000 description 1
239000008186 active pharmaceutical agent Substances 0.000 description 1
208000005298 acute pain Diseases 0.000 description 1
239000000654 additive Substances 0.000 description 1
239000002156 adsorbate Substances 0.000 description 1
239000003513 alkali Substances 0.000 description 1
150000001342 alkaline earth metals Chemical class 0.000 description 1
230000004075 alteration Effects 0.000 description 1
229910021529 ammonia Inorganic materials 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
208000007502 anemia Diseases 0.000 description 1
230000000845 anti-microbial effect Effects 0.000 description 1
230000002421 anti-septic effect Effects 0.000 description 1
230000000890 antigenic effect Effects 0.000 description 1
229940064004 antiseptic throat preparations Drugs 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
230000008901 benefit Effects 0.000 description 1
239000003613 bile acid Substances 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
230000008827 biological function Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
208000005634 blind loop syndrome Diseases 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
230000017531 blood circulation Effects 0.000 description 1
238000004364 calculation method Methods 0.000 description 1
229940095731 candida albicans Drugs 0.000 description 1
210000000748 cardiovascular system Anatomy 0.000 description 1
239000000969 carrier Substances 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
238000002512 chemotherapy Methods 0.000 description 1
230000000052 comparative effect Effects 0.000 description 1
IQFVPQOLBLOTPF-HKXUKFGYSA-L congo red Chemical compound [Na+].[Na+].C1=CC=CC2=C(N)C(/N=N/C3=CC=C(C=C3)C3=CC=C(C=C3)/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-HKXUKFGYSA-L 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
230000001687 destabilization Effects 0.000 description 1
230000001066 destructive effect Effects 0.000 description 1
230000006866 deterioration Effects 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
235000015872 dietary supplement Nutrition 0.000 description 1
102000038379 digestive enzymes Human genes 0.000 description 1
108091007734 digestive enzymes Proteins 0.000 description 1
210000002249 digestive system Anatomy 0.000 description 1
230000023011 digestive tract development Effects 0.000 description 1
229940008099 dimethicone Drugs 0.000 description 1
230000003292 diminished effect Effects 0.000 description 1
AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
239000003937 drug carrier Substances 0.000 description 1
201000006549 dyspepsia Diseases 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
239000002158 endotoxin Substances 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
210000003608 fece Anatomy 0.000 description 1
239000012530 fluid Substances 0.000 description 1
235000013305 food Nutrition 0.000 description 1
239000007789 gas Substances 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
210000002175 goblet cell Anatomy 0.000 description 1
239000000665 guar gum Substances 0.000 description 1
235000010417 guar gum Nutrition 0.000 description 1
229960002154 guar gum Drugs 0.000 description 1
230000003394 haemopoietic effect Effects 0.000 description 1
230000035876 healing Effects 0.000 description 1
230000002949 hemolytic effect Effects 0.000 description 1
238000000265 homogenisation Methods 0.000 description 1
230000007954 hypoxia Effects 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
230000007813 immunodeficiency Effects 0.000 description 1
238000011534 incubation Methods 0.000 description 1
230000002757 inflammatory effect Effects 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
208000014674 injury Diseases 0.000 description 1
230000003993 interaction Effects 0.000 description 1
230000008991 intestinal motility Effects 0.000 description 1
210000004347 intestinal mucosa Anatomy 0.000 description 1
230000009545 invasion Effects 0.000 description 1
208000002551 irritable bowel syndrome Diseases 0.000 description 1
239000008101 lactose Substances 0.000 description 1
230000037356 lipid metabolism Effects 0.000 description 1
208000019423 liver disease Diseases 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
210000004379 membrane Anatomy 0.000 description 1
239000012528 membrane Substances 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
STZCRXQWRGQSJD-GEEYTBSJSA-M methyl orange Chemical compound [Na+].C1=CC(N(C)C)=CC=C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 STZCRXQWRGQSJD-GEEYTBSJSA-M 0.000 description 1
229940012189 methyl orange Drugs 0.000 description 1
238000002156 mixing Methods 0.000 description 1
230000004899 motility Effects 0.000 description 1
210000004877 mucosa Anatomy 0.000 description 1
230000002887 neurotoxic effect Effects 0.000 description 1
235000015816 nutrient absorption Nutrition 0.000 description 1
230000000771 oncological effect Effects 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
210000000496 pancreas Anatomy 0.000 description 1
239000006072 paste Substances 0.000 description 1
244000052769 pathogen Species 0.000 description 1
230000008756 pathogenetic mechanism Effects 0.000 description 1
230000009054 pathological process Effects 0.000 description 1
230000035515 penetration Effects 0.000 description 1
238000005502 peroxidation Methods 0.000 description 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
229940068196 placebo Drugs 0.000 description 1
239000000902 placebo Substances 0.000 description 1
210000002826 placenta Anatomy 0.000 description 1
230000002980 postoperative effect Effects 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
230000002797 proteolythic effect Effects 0.000 description 1
229940126409 proton pump inhibitor Drugs 0.000 description 1
230000005855 radiation Effects 0.000 description 1
238000001959 radiotherapy Methods 0.000 description 1
239000002994 raw material Substances 0.000 description 1
206010039447 salmonellosis Diseases 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
230000028327 secretion Effects 0.000 description 1
229940007046 shigella dysenteriae Drugs 0.000 description 1
230000035939 shock Effects 0.000 description 1
150000003376 silicon Chemical class 0.000 description 1
239000002210 silicon-based material Substances 0.000 description 1
229940083037 simethicone Drugs 0.000 description 1
239000007787 solid Substances 0.000 description 1
241000894007 species Species 0.000 description 1
238000002798 spectrophotometry method Methods 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
238000003860 storage Methods 0.000 description 1
239000000758 substrate Substances 0.000 description 1
239000013589 supplement Substances 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
230000002195 synergetic effect Effects 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
229940118696 vibrio cholerae Drugs 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/732—Pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/734—Alginic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Natural Medicines & Medicinal Plants (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Inorganic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Nutrition Science (AREA)
Oil, Petroleum & Natural Gas (AREA)
Biotechnology (AREA)
Physiology (AREA)
Biochemistry (AREA)
Mycology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Microbiology (AREA)
Toxicology (AREA)
Alternative & Traditional Medicine (AREA)
Zoology (AREA)
Botany (AREA)
Medical Informatics (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Compositions Of Macromolecular Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DE102012109727A 2011-11-23 2012-10-12 Enterosorbenszusammensetzung Pending DE102012109727A1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
UA201113802		2011-11-23
UAA201113802A UA103089C2 (uk)	2011-11-23	2011-11-23	Композиційний ентеросорбент на основі кремнієвого полімеру

Publications (1)

Publication Number	Publication Date
DE102012109727A1 true DE102012109727A1 (de)	2013-05-23

Family

ID=48222154

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE102012109727A Pending DE102012109727A1 (de)	2011-11-23	2012-10-12	Enterosorbenszusammensetzung

Country Status (5)

Country	Link
US (1)	US20130129659A1 (uk)
CZ (1)	CZ308038B6 (uk)
DE (1)	DE102012109727A1 (uk)
PL (1)	PL401166A1 (uk)
UA (1)	UA103089C2 (uk)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2591791C2 (ru) *	2014-09-30	2016-07-20	Александр Владимирович Диковский	Композиция для детоксикации организма
UA112474C2 (uk) *	2014-11-20	2016-09-12	Юрій Захарович Толчеєв	Спосіб одержання пастоподібного сорбенту на основі гідрогелю метилкремнієвої кислоти
RU2612011C1 (ru) *	2015-10-15	2017-03-01	государственное бюджетное образовательное учреждение высшего профессионального образования "Пермский государственный медицинский университет имени академика Е.А. Вагнера" Министерства здравоохранения Российской Федерации	Энтеросорбент
CN113773989B (zh) *	2021-08-30	2023-06-13	大连工业大学	植物乳杆菌y12所产胞外多糖在缓解由福氏志贺氏菌引起痢疾病症的应用
WO2024205551A1 (ru) *	2023-03-31	2024-10-03	Вадим Алексеевич Козловский	Фармацевтическая композиция для энтеральной детоксикации и способ ее изготовления

Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2048123C1 (ru)	1991-12-10	1995-11-20	Николай Николаевич Терещенко	Способ производства продукта для диетического питания
UA54103A (uk)	2002-05-14	2003-02-17	Львівський Державний Медичний Університет Ім. Данила Галицького	Спосіб відновлення внутрішньокишкової флори у пацієнтів з гострим деструктивним панкреатитом в ранньому післяопераційному періоді
UA62152A (en)	2002-12-29	2003-12-15	Danylo Halytskyi Lviv State Ne	Method for decreasing volume of intestinal evacuations and restoring intestinal microflora in patients with ileostoma at early postoperative stage
UA24987U (en)	2007-02-16	2007-07-25	Kyiv Nat Univ Tech & Design	Drive of round-knitting machine
UA82774C2 (uk)	2006-09-20	2008-05-12	Tolcheiev Yurii Zakharovych	Спосіб одержання сорбенту на основі гідрогелю метилкремнієвої кислоти

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1306128A1 (en) *	2001-10-29	2003-05-02	Tenaxis Gmbh	Sorptive composite materials
PL2116564T3 (pl) *	2007-02-09	2014-07-31	Bioline Pharmaceutical Ag	Absorbent i sposób jego wytwarzania
ITMI20071214A1 (it) *	2007-06-15	2008-12-16	S I I T Srl Servizio Internazi	Composizioni a base di componenti prebiotici ed immunogenici per la prevenzione e il trattamento di disturbi gastroenterici da disbiosi e/o alterazioni della normale flora intestinale
RU2433751C2 (ru) *	2009-05-05	2011-11-20	Александр Владимирович Диковский	Композиция для нормализации микрофлоры и очищения организма от токсинов и способ оздоровления организма
RU2455012C1 (ru) *	2011-01-11	2012-07-10	Учреждение Российской академии медицинских наук Научно-исследовательский институт медицинских проблем Севера Сибирского отделения РАМН	Способ энтеральной детоксикации при лечении иммунных нарушений
UA64357U (uk) *	2011-03-16	2011-11-10	Алєксандр Владіміровіч Діковскій	Композиція для очищення організму від токсинів і нормалізації мікрофлори кишечнику

2011
- 2011-11-23 UA UAA201113802A patent/UA103089C2/uk unknown
2012
- 2012-09-12 US US13/611,661 patent/US20130129659A1/en not_active Abandoned
- 2012-10-11 PL PL401166A patent/PL401166A1/pl unknown
- 2012-10-12 DE DE102012109727A patent/DE102012109727A1/de active Pending
- 2012-10-16 CZ CZ2012706A patent/CZ308038B6/cs unknown

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2048123C1 (ru)	1991-12-10	1995-11-20	Николай Николаевич Терещенко	Способ производства продукта для диетического питания
UA54103A (uk)	2002-05-14	2003-02-17	Львівський Державний Медичний Університет Ім. Данила Галицького	Спосіб відновлення внутрішньокишкової флори у пацієнтів з гострим деструктивним панкреатитом в ранньому післяопераційному періоді
UA62152A (en)	2002-12-29	2003-12-15	Danylo Halytskyi Lviv State Ne	Method for decreasing volume of intestinal evacuations and restoring intestinal microflora in patients with ileostoma at early postoperative stage
UA82774C2 (uk)	2006-09-20	2008-05-12	Tolcheiev Yurii Zakharovych	Спосіб одержання сорбенту на основі гідрогелю метилкремнієвої кислоти
UA24987U (en)	2007-02-16	2007-07-25	Kyiv Nat Univ Tech & Design	Drive of round-knitting machine

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
A.M. Bojarskaja, O.I. Osadtschaja, A.A. Zhernow, O.N. Kowalenko. Verwendung des EnteroSorbenss ENTEROSGEL bei komplexer Behandlung der Dysbiose bei Kinder mit der Verbrennungskrankheit // Medizin der Notfallzustände. - 2006 - Nr. 1(2). - S. 50-53
Bengmark S. Colonic food: pre- and probiotics. Am J Gastroenterol 2000; 95 (1) Suppl: S5-7
Chartschenko N.V., Tschernenko V.V. Moderne Vorgehensweise zur Korrektion der Darm-Dysbiose (methodischen Empfehlungen) K. 2000. - 28 S.
I.A. Supanetz, N.V. Besdetko, E.F. Grintzov, Y.P. Besuglaja. Pharmazeutische Betreuung: Symptomatische Behandlung der Störungen von Funktion des Magen-Darm-Traktus. Meteorismus. Dysbakteriose.//Verlag "Provisor". - 2002. - Nr. 16. - S.32
M.D. Ardatskaja. Klinische Verwendung von Nahrungsfasern, Moskau, 2010. 48 S.
Metcalf TJ, Irons TG, Sher LD, Young PC. Simethicone in the treatment of infant colic: A randomized, placebo-controlled, multicenter trial//Pediatrics, 1994; 94:29-34.
Methodischen Empfehlungen. Vorklinische Untersuchung von Enterosorbentien. Kiew: 2010. 62 S.
Tschernobrowyj V.N., Palij I.G. Verwendung des Präparates "Enterosgel" für die Behandlung der Darm-Dysbakteriose//Medizin-biologeschen Aspekte der Verwendung des Präparates "Enterosgel" für die Behandlung verschiedenen Krankheiten. - K., 2007. - S. 76-79

Also Published As

Publication number	Publication date
UA103089C2 (uk)	2013-09-10
CZ2012706A3 (cs)	2013-06-05
PL401166A1 (pl)	2013-05-27
CZ308038B6 (cs)	2019-11-13
US20130129659A1 (en)	2013-05-23

Publication	Publication Date	Title
DE69533593T2 (de)	2005-10-13	Zubereitungen zur behandlung von gastrointestinalen störungen, welche arabinogalactan und polyphenole von larix enthalten.
EP2124972B1 (de)	2012-06-13	Verwendung einer zusammensetzung aus mineralstoffen und gegebenenfalls acetogenen und/oder butyrogenen bakterien zur vermeidung oder reduzierung von gasbildung im dickdarm eines säugetiers und dadurch bedingter abdominaler beschwerden
US9907827B2 (en)	2018-03-06	Prebiotic mixture
DE202016008919U1 (de)	2020-09-07	Zusammensetzungen zur Verwendung bei der Prävention oder Behandlung von gastrointestinalen Infektionen/Entzündungen bei Säuglingen oder Kleinkindern
MX2010011995A (es)	2010-12-02	Metodos y estuches para el tratamiento de condiciones y trastornos inflamatorios del intestino.
EP2228067B1 (de)	2013-12-11	Probiotische Zusammensetzung und deren Verwendung
DE102012109727A1 (de)	2013-05-23	Enterosorbenszusammensetzung
DE69100314T2 (de)	1993-12-16	Behandlung von Clostridium difficile Diarrhöe und Pseudomembrankolitis.
DE102008059070B4 (de)	2019-05-16	Zusammensetzung zur therapeutischen oder prophylaktischen Behandlung von Durchfallerkrankungen und/oder zur Aufrechterhaltung und/oder Wiederherstellung der natürlichen Darmflora, Dosiereinheit, Verpackungseinheit und Verwendung der Zusammensetzung
EP2358642B2 (de)	2022-12-07	Klinoptilolith oder klinoptilolithhaltige gemische
EP4289479A2 (de)	2023-12-13	1,8-cineol enthaltende zusammensetzung für die therapeutische verwendung
EP3556226B1 (de)	2021-01-20	Komplex-synbiotikum zum aufbau einer gesunden darmflora
RU2491941C1 (ru)	2013-09-10	Композиционный энтеросорбент
DE102017113263A1 (de)	2018-12-20	Pharmazeutische Zusammensetzung enthaltend Bakterienstämme aus der Familie der Lactobacillaceae und Molke
DE19940011B4 (de)	2009-04-02	Alginataufbereitung und deren Verwendung
DE20121186U1 (de)	2002-05-02	Zusammensetzungen zur Nahrungsmittel- und Tierfutterergänzung
DE202007008818U1 (de)	2008-07-24	Zusammensetzung zur Behandlung von Infekten
DE69634542T2 (de)	2006-03-30	Verwendung von einer dehydrierten zubereitung von propionischen bakterien zur herstellung einer diätetischen zusammensetzung zur verbesserung des biologischen gleichgewichts der darmflora
EP1886690A2 (de)	2008-02-13	Pharmazeutische Zusammensetzung zur Anwendung bei Nahrungsmittelunverträglichkeiten
DE602005001892T2 (de)	2008-04-24	Nutrazeutische Zusammensetzungen enthaltend Milchenzyme als Symbiose
DE202011004425U1 (de)	2012-03-27	Zusammensetzung zur Anwendung bei Verdauungsbeschwerden
EP1383523B1 (de)	2006-06-07	Kombinationspräparat zur behandlung des diabetes mellitus
DE2715384A1 (de)	1978-10-12	Arzneimittel gegen diarrhoeen
Ivanovna et al.	2017	Influence of biologically active substances from Kombucha ( Medusomycesgisevii) on rat gut microbiota with experimental antibiotic-associated dysbiosis
WO2016005140A1 (de)	2016-01-14	Zusammensetzung zur behandlung von magenbeschwerden

Legal Events

Date	Code	Title	Description
2019-06-19	R012	Request for examination validly filed
2022-01-05	R016	Response to examination communication